<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01845090</url>
  </required_header>
  <id_info>
    <org_study_id>SMHLANFGF23</org_study_id>
    <nct_id>NCT01845090</nct_id>
  </id_info>
  <brief_title>The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23</brief_title>
  <official_title>Compared the Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 With Calcium Carbonate in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Camillians Saint Mary's Hospital Luodong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Camillians Saint Mary's Hospital Luodong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effect of lanthanum carbonate with calcium carbonate on serum FGF23 levels in
      hemodialysis patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators enrolled patients on maintenance hemodialysis and randomized them to two
      groups. One group will receive lanthanum carbonate and another group will receive calcium
      carbonate. The investigators will compare serum FGF23 levels between two groups after they
      receive above medication for 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum level of fibroblast growth factor</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Other Nonspecific Abnormal Serum Enzyme Levels</condition>
  <arm_group>
    <arm_group_label>Lanthanum carbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lanthanum carbonate 375mg~750 mg tid for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium carbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Calcium carbonate 500mg~1000 mg tid for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lanthanum carbonate</intervention_name>
    <description>the effect on serum FGF23</description>
    <arm_group_label>Lanthanum carbonate</arm_group_label>
    <other_name>Fosrenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium Carbonate</intervention_name>
    <description>Calcium carbonate 500mg~1000 mg tid for 6 months</description>
    <arm_group_label>Calcium carbonate</arm_group_label>
    <other_name>TOP-CAL(CaCO3)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  Chronic renal failure on maintenance hemodialysis 3 times a week for at least 3 months
             Serum calcium:8-10.5 mg/dL

          -  Serum phosphate:3.5-6 mg/dL(before washout period)

          -  Serum phosphate â‰§6 mg/dL after washout period

          -  Serum i-PTH: 150-600 pg/mL

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Post parathyroidectomy

          -  Life expectancy&lt; 6 months

          -  Liver disease(hepatitis B,C or liver dysfunction)

          -  Severe gastrointestinal disorders or other severe comorbidity

          -  Poor compliance

          -  Intolerance to lanthanum or calcium carbonate

          -  Active infection

          -  Malnutrition(serum albumin&lt;3 g/dL or clinical assessment)

          -  Kt/V&lt; 1.2 (inadequate dialysis)

          -  Serum phosphate&gt;7.5 mg/dL after washout period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shih-Ching Tsai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Mary's hospital-Lotung</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Ming Chang, MD</last_name>
    <email>ynk123.tw@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Mary's hospital-Lotung</name>
      <address>
        <city>Taipei</city>
        <zip>265</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Ming Chang, MD</last_name>
      <email>ynk123.tw@yahoo.com.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2013</study_first_submitted>
  <study_first_submitted_qc>May 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2013</study_first_posted>
  <last_update_submitted>May 1, 2013</last_update_submitted>
  <last_update_submitted_qc>May 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Mitogens</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

